Hong Kong Stock Market Surges | Concept Stocks of Innovative Drugs Experience a Brand New Breakthrough with Over 600 Drugs Passing Initial Approval "Medical Insurance + Commercial Insurance" Dual Catalogue Negotiations Enter Substantial Stage

We have learned from the Smart Finance APP that the concept stocks of innovative drugs are experiencing a new outbreak. As of the time of publication, Rongchang Biology (09995.HK) rose by 17.16% to HK$81.6; Kangnaoya-B (02162.HK) rose by 13.66% to HK$72.8; Kangfang Biology (09926.HK) rose by 13.57% to HK$94.6; and Xinda Biology (01801) rose by 7.39% to HK$80.7.